Taysha Gene Therapies Inc (NASDAQ:TSHA) currently has a daily average trading volume of 3.54M but it saw 4210780 shares traded in last market. With a market cap of 693.06M USD, the company’s current market price of $2.65 came falling about -0.75 while comparing to the previous closing price of $2.67. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.32 and as low as $1.05.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BMO Capital Markets which initiated the stock as “Outperform” in its note to investors issued on June 27, 2024, recommending a price target of $5 for it. Jefferies issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $14 and $1.50.
Over the week, TSHA’s stock price is moving -7.99% down while it is 13.25% when we observe its performance for the past one month. Year-to-date it is 53.18% up and over the past year, the stock is showing a downside performance of -32.40%.
Currently, Taysha Gene Therapies Inc’s total number of outstanding shares is 261.53M with 15.00% of that held by the insiders while 67.23% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -75.53% and return on equity (ROE) at -159.34%. Stock’s beta reads 1.01. Stock has a price to book (P/B) ratio of 9.87 while price to sale or P/S ratio amounts to 95.99. Its return on asset (ROA) is -59.56% on average.
